The year gone by has been a year full of uncertainties in the market and events like the US-China Trade War, the US-Iran tension, Brexit, the Hong Kong protests and many more have amplified investor anguish.
Amidst these uncertain times, we have seen some of the stocks performing well while some of the others losing their charm among investors. With the overhang due to continued uncertainties from the previous year and persisting turbulence on the economic front aggravated by the coronavirus outbreak, there are some ASX-listed stocks that have returned more than 100% in the prior one year.
Let us look at some of the ASX listed stocks which have multiplied 2x in the last one year.
One of the most talked-about stocks during the previous year was Afterpay Limited (ASX:APT). However, the stock has maintained its attractiveness and lustre entering into 2020 with around 30% appreciation in the last one month.
Being a technology-driven payments company, APT provides Buy Now, Receive Now, Pay Later services in order to make the process of purchasing feel great for its global customer base. In a short period of its existence, the company has acquired a significant number of users, both merchants as well as retail customers, and has penetrated into various markets and sectors internationally.
The company achieved $1.0 billion of monthly underlying sales in November 2019, which was the company’s highest monthly performance since inception.
By the end of November 2019, the company had a whooping active customer base of above 6.6 million and:
- The US now has a customer base of equivalent number (over 3 million) compared to New Zealand and Australia in 19 months after launch;
- In the UK, more than 500,000 active customers have transacted with Afterpay after approximately seven months from launch;
Afterpay witnessed continuous strong growth in the following:
- Australia and New Zealand in terms of both new and repeat customers;
- merchant portfolio and pipeline have witnessed strong traction with 42,500 active merchants now offering Afterpay to their customers;
On 7 February 2020, the APT stock closed the day’s trade at a price of $39.440, up by 1.154% intraday, with a market capitalisation of $10.32 billion.
During the last one year, the stock has delivered 120.66% returns till 06 February 2020.
Let us now focus on another ASX-listed information technology sector player with robust growth in its stock price within the prior one year.
Payments service provider, EML PAYMENTS LIMITED (ASX:EML) is a globally trusted brand in the payments business which aims to create amazing, swift and protected payment solutions that connect the company’s customers to their customers on the go anytime, wherever money is in motion.
The company’s portfolio offers innovative financial technology that offers the following
- Solutions for payouts;
- Incentives and rewards;
- Supplier payments;
EML enables its customers with increased control, transparency and flexibility in the payment processes along with increased efficiency and security from start to finish, improving customer service and increasing brand loyalty.
EML is the largest provider of payment solutions to the Salary Packaging industry with more than 185,000 benefit accounts already in the market, and the EML stock has provided a return of 268.51% during the last one year till 06 February 2020.
An acknowledgment of EML’s leading position in the Salary Packaging industry is the recent EML’s 5 + 2-year agreement with NSW Health, wherein EML shall be the provider of branded General-Purpose Reloadable card programs for employee Salary Packaging.
During the day’s trade on 07 February 2020, the EML stock closed at a price of $5.180, with a market capitalisation of $1.71 billion.
We shall now discuss the healthcare stocks with robust performance in the last one year.
Pro Medicus Limited (ASX:PME) and Nanosonics Limited (ASX:NAN) have provided returns of 103.1% and 104.29% respectively within the previous one year. Both healthcare stocks have shown strong performance in terms of price returns.
Being leading medical imaging IT provider, Pro Medicus Limited provides a complete array of radiology IT software and services through globally located
- Imaging centres
- Health care groups.
Pro Medicus was founded in 1983 and presently operates globally through its offices in Melbourne, Berlin and San Diego.
Visage Imaging, Inc., wholly-owned U.S. subsidiary of Pro Medicus, recently signed a 5-year contract with Nines based in Palo Alto, under which the Visage 7 technology shall be hosted in Google Cloud Platform and is expected to offer Nines with an extremely scalable and highly optimised platform.
The contract is expected to result in base revenue of more than $ 6 million to Pro Medicus over the contract life and brings into light the prospects for considerable upside.
Nanosonics Limited possesses intellectual property (IP) concerning a distinctive disinfection and purification tech which can be suitable for an array of markets with Initial market applications devised to reprocess the reusable medical instruments.
Nanosonics has continued to strengthen and deliver excellent growth in its core trophon business and has made significant investments over the period and currently operates through its multiple offices located globally.
The PME stock closed the day’s trade at a price of $26.220, down by 0.456% intraday with a market capitalisation of $2.74 billion on 7 February 2020.
On the other hand, the NAN stock closed the day’s trade with a gain of 2.657 % intraday reaching to $7.340, with a market capitalisation of $2.15 billion on 7 February 2020.
We shall now look at an ASX-listed stock from the metals and mining sector.
The S&P/ASX 300 Metals and Mining index closed at 4,487.4, losing 1.09% during the day on 07 February 2020. Metals and mining stock, Fortescue Metals Group Ltd (ASX: FMG) also fell by 3.298 % during the day’s trade today and reached $10.850.
However, the performance of FMG stock during the last one yeast reflects 101.18% returns during the last one year till 06 February 2020.
The company recently communicated it’s USD 450 million Pilbara Generation Project which is the next stage of its Pilbara Energy Connect program that complements the USD 250 million Pilbara Transmission Project announced in October 2019 and is expected to offer low-cost power to the energy-efficient Iron Bridge Magnetite Project.
The company anticipates its investment to address the issue of unavailability of an integrated transmission network in the Pilbara that has been a primary hindrance to the entry of renewable energy service providers on a larger scale.
On the environmental front, the company looks forward to preventing up to 285,000 tonnes of CO2e per year in emissions, as compared to generating electricity solely from gas, by installing 150MW of solar PV under the Pilbara Generation Project.
Moreover, the company reported shipments of 46.4 million tonnes (mt) and cash production costs (C1) of US$12.54 per wet metric tonne (wmt) for the December 2019 quarter. It is not the first time that Fortescue has achieved outstanding results demonstrated by multiple records across the operations, including the following:
- Record shipments of 88.6mt during the first half of FY20;
- Maintaining its industry-leading cost position below US$13/wmt;
Considering the strong performance of the company during the 1H 2020, the company anticipates shipments to be at the upper end of its guidance range of 170 – 175mt and has lowered the C1 cost guidance to a range of US$12.75 – US$13.25/wmt for FY20.
The FMG stock closed the day’s trade at a price of $10.850 with a market capitalisation of $34.55 billion on 7 February 2020.
The above-discussed companies have produced robust performance during the last year while also increasing the value of stock prices significantly. Moreover, as opportunities arise in the near term, these stocks may progress and expand their spread of operations over the coming years.
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.